A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived rats
Conclusions:
17β-Estradiol exhibits the greatest efficacy on the attenuation of obesity with the least harmful effect on skeletal muscle in a model of menopause with obesity, yet its effect on the treatment of hyperlipidemia is inferior to those of standard lipid-lowering agents.
Source: Menopause - Category: OBGYN Tags: Original Studies Source Type: research
More News: Atorvastatin Calcium | Cholesterol | Diets | Eating Disorders & Weight Management | Estradiol | High Fat | Insulin | Lipitor | Men | Menopause | Mitochondria | Nutrition | Obesity | OBGYN | Physiology | Statin Therapy | Study | Zivast